Lisa Malter, MD

Opinion

Selecting therapies in moderate to severe inflammatory bowel disease: Key factors in decision making

Author:

Ariela K. Holmer, MD

Shannon Chang, MD, MBA

Lisa Malter, MD

While efficacy is often considered first when choosing a drug, other critical factors play a role in tailoring a treatment plan.

• Read More